Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis

BACKGROUND: Immune-mediated diarrhea and colitis (IMDC) is currently diagnosed and monitored by evaluating clinical symptoms. Deep remission is determined by endoscopic and histologic evaluation of the disease process. However, repeating these invasive procedures frequently can become cumbersome. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Fangwen, Wang, Xuemei, Glitza Oliva, Isabella C, McQuade, Jennifer L, Wang, Jennifer, Zhang, Hao Chi, Thompson, John A, Thomas, Anusha S, Wang, Yinghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805368/
https://www.ncbi.nlm.nih.gov/pubmed/33436487
http://dx.doi.org/10.1136/jitc-2020-002058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805368/
https://www.ncbi.nlm.nih.gov/pubmed/33436487
http://dx.doi.org/10.1136/jitc-2020-002058

Ejemplares similares